Mark Chapman, BSc (Hons), PgDip, Health Economics MBA

Mark has held many roles that champion the value of Healthtech for patients. including inward investment and research and development.

Mark has over 35 years experience in the NHS and Healthtech Industry, most recently as the former Board Executive for Healthtech at The National Institute for Health and Care Excellence (NICE).

Mark initially trained as a Clinical Physiologist, and worked for 10 years within the UK NHS, Tertiary Cardiac Care, with a specialist interest in complex cardiac devices. Which is where his passion for all things Healthtech and patient access was born.

Moving into Industry in 2001, holding various clinical and commercial and Policy roles. Prior to Joining NICE in 2022, Mark was the Director of Health Economics and Commissioning for UK & Ireland at Medtronic.

In parallel, Mark has held many roles that champion the value of Healthtech for patients, inward investment and research and development. Including committee member on NICE technology appraisal programme, membership of External Advisory Boards for the Engineering and Physical Research Council. (EPSRC), Numerous NHS England Task and Finish groups and Policy advisory work for Office for Life science, Department of Business. He also continues to mentor NHS Innovators via the NHS Mentor programme.

I back MyCareQuestions because it hands patients the tools to advocate for themselves — regardless of background or literacy. In my NHS years, I saw too many people leave consultations without the right questions asked. This fixes that. Equity isn’t just policy — it’s every single appointment.

Every patient deserves a consultation rooted in respect, rigour, and equity. From the moment a patient enters, the clinician should create a space where they feel genuinely heard — not processed. Active listening must underpin the entire encounter, free from assumptions shaped by background, postcode, or perceived complexity.

The clinician should take a thorough, structured history, ensuring presenting symptoms are explored fully rather than prematurely filtered. Diagnostic thinking must be systematic: no patient should leave without a clear clinical rationale for next steps, whether that means investigation, referral, or watchful waiting — and crucially, that decision should never be influenced by who the patient is, but solely by what they need.

Clear communication of findings, honest discussion of options, and shared decision-making are non-negotiable. Every patient — regardless of age, ethnicity, socioeconomic status, or health literacy — should leave better informed, appropriately supported, and confident their care reflects clinical need, not circumstance.